How did USANA's revenue and expenses trend in Q4 2024 compared to previous quarters?

**USANA's revenue and expenses in Q4 2024 showed an increase in revenue compared to the previous quarter.** 1. **Revenue Trend**: The total revenue for Q4 2024 was $213.61 million, which is higher than the revenue of $200.22 million reported in Q3 2024. This indicates a positive trend in revenue, suggesting that the company's performance improved or stabilized after the previous quarter. 2. **Expense Information**: Unfortunately, the total expenses for Q4 2024 are not available. However, the absence of this data does not negate the observation of the revenue trend. The focus on revenue growth is pertinent when assessing the company's performance, especially in the context of increased sales. 3. **Conclusion**: Based on the available data, USANA experienced a notable increase in revenue from Q3 to Q4 2024. This uptick could be indicative of successful marketing strategies, operational improvements, or other factors contributing to higher sales. The absence of expense data prevents a comprehensive analysis of the company's financial health during this period, but the revenue growth is a positive signal for the company's performance. |code|Ticker|Name|Date|Total Revenue|Total Expenses|market_code| |---|---|---|---|---|---|---| |USNA|USNA.N|Usana Health Sciences|2024 Q1|2.278E8||169| |USNA|USNA.N|Usana Health Sciences|2024 Q2|2.12869E8||169| |USNA|USNA.N|Usana Health Sciences|2024 Q3|2.00221E8||169| |USNA|USNA.N|Usana Health Sciences|2024 Q4|2.13613E8||169| |code|Ticker|Name|Date|Total Revenue|Total Expenses|market_code| |---|---|---|---|---|---|---| |USNA|USNA.N|Usana Health Sciences|2023 Q4|2.21083E8||169| |USNA|USNA.N|Usana Health Sciences|2024 Q1|2.278E8||169| |USNA|USNA.N|Usana Health Sciences|2024 Q2|2.12869E8||169| |USNA|USNA.N|Usana Health Sciences|2024 Q3|2.00221E8||169|